ArticleCellular and molecular life sciences : CMLS2025
USP5-induced deubiquitination of P4HB alleviates ER stress-mediated apoptosis in intestinal ischemia/reperfusion.
Article in Cellular and molecular life sciences : CMLS, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- USP5 in cancer: a therapeutic window into metabolism and drug resistance.Journal of translational medicine · 2026Review
- Exosomes in inflammatory tissue injury: key pathogenic factors and promising therapeutic agents.Frontiers in immunology · 2026Review
- USP5 promotes glycolysis in cervical cancer by stabilizing FOXM1.American journal of cancer research · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
Intestinal ischemia/reperfusion (I/R) is a severe pathophysiological process that occurs in a variety of clinical conditions and can trigger multiple life-threatening syndromes. Intestinal I/R is associated endoplasmic reticulum (ER) stress. Prolyl 4-hydroxylase subunit beta (P4HB) contributes significantly to maintaining ER redox homeostasis, which is affected by I/R injury. Nevertheless, the molecular mechanism of P4HB expression and function in intestinal I/R is still unknown. In our study, we discovered that the expression of P4HB was clearly downregulated in the intestine of mice at the reperfusion stage and in Caco2 cells at the reoxygenation stage. In addition, P4HB-knockdown mice exhibited clearly enhanced ER stress-mediated apoptosis of intestinal tissue under intestinal I/R, whereas P4HB overexpression in Caco2 cells alleviated ER stress-mediated apoptosis under HR. Furthermore, via bioinformatics screening of proteins that interact with P4HB, ubiquitin-specific protease 5 (USP5) was identified as a critical factor in the abnormal expression of P4HB. USP5 interacts with P4HB and remains stable by removing ubiquitin. In vivo, P4HB knockdown counteracted the effect of USP5 overexpression on alleviating ER stress-mediated apoptosis in response to intestinal I/R. In summary, this study revealed that P4HB plays a crucial role in regulating ER stress-mediated apoptosis and identified USP5, which is a novel mediator of P4HB, as a prospective target for the treatment of intestinal I/R.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.